Assessment of Serum Podocalyxin as a Biomarker for Diabetic Nephropathy in Type 2 Diabetes patients in Duhok City. JLBSR [Internet]. 2022 Nov. 4 [cited 2026 Jan. 9];3(02):71-5. Available from: https://jlbsr.org/index.php/jlbsr/article/view/75